SARS-CoV-2の非RBDスパイクエピトープの流行性,保護性,および収束性IgG認識
William N Voss1, Yixuan J Hou2, Nicole V Johnson1
1Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
まとめ
SARS-CoV-2 感染後のほとんどの抗体は,RBD 以外のスパイクタンパク質を標的とする. これらの非RBD抗体は,N-ターミナルドメイン (NTD) を標的とする抗体は,流行しており,COVID-19の変種に対する保護に影響を与えています.
科学分野:
- 免疫学
- ウイルス学
- プロテオミクス
背景:
- SARS-CoV-2感染後の免疫グロブリンG (IgG) 抗体の特異的な標的は,大部分が特徴づけられていない.
- 抗体結合部位を理解することは,SARS-CoV-2およびその変種に対する効果的なワクチンおよび治療薬の開発に不可欠です.
研究 の 目的:
- SARS-CoV-2 感染後のプラズマにおける IgG 抗体の分子構成と結合エピトープを決定する.
- SARS-CoV-2のスパイクタンパク質の異なる領域を標的とした抗体の有病率と特性を調査する.
主な方法:
- 回復期におけるSARS-CoV-2のスパイクグリコタンパク質に対するIgG抗体レパートリーのタンパク質分解.
- 特定された抗体系統の遺伝的,構造的,機能的特徴.
- ウイルス変異に対する抗体反応の分析
主要な成果:
- IgG応答の大部分 (> 80%) は,スパイクタンパク質の受容体結合領域 (RBD) 以外のエピトープを標的とする.
- 抗体反応の有意な部分は,N末端領域 (NTD) を標的とするものを含む,いくつかの支配的なIgG系統に起因する.
- "公的"抗体による再発性NTDエピトープは,懸念されるSARS-CoV-2変種で頻繁に変異する.
結論:
- SARS-CoV-2感染後のプラズマIgG抗体は主に非RBDエピトープ,特にNTDを標的とする.
- "公共"のNTD向け抗体は広く存在し,抗ウイルス保護に役立っています.
- NTDエピトープの頻繁な変異は,抗体脱出とCOVID-19ワクチンおよび治療法の有効性に影響を与える.
さらに関連する動画
関連する概念動画
Cross-reactivity
31.9K
Overview
31.9K
Conjugated Proteins
22.7K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
22.7K
Diversity of Antigen Receptors
1.1K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.1K
Antigens Involved in Adaptive Immunity
874
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
874
Enzyme-Linked Immunosorbent Assay
15.5K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
15.5K
Immunoglobulin-like Cell Adhesion Molecules
3.7K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.7K


